Greg Kennelty | Authors


The Impact of WHO's Tumor Reclassifications on Brain Cancer Care

January 13, 2017

Arie Perry, MD, chief of neuropathology at UCSF in San Francisco, California, discusses what oncologists should be aware of when diagnosing patients after these reclassifications, how it could change pathology, as well as a discussion on hereditary tumors.

Expert Discusses Treating Patients With NRAS-Mutated Colorectal Cancer

January 12, 2017

Maria Ignez Braghiroli, MD, discusses a study that parsed out patients with solely NRAS-mutated colorectal cancer, what the current treatment paradigm is for these patients, and how the mutation status of a patient with colorectal cancer may affect their treatment.

Nab-Paclitaxel Beneficial Over Paclitaxel In Breast Cancer Subsets

January 03, 2017

Sibylle Loibl, MD, PhD, discusses the most recent subanalysis of the GeparSepto trial, how the drugs match up in terms of toxicities, and a separate set of data looking at patients with breast cancer who are also pregnant.

Lapatinib May Aid In Control Of Brain Metastases In HER2-Positive Breast Cancer

January 03, 2017

Julia White, MD, discusses the upcoming phase II trial, the toxicities associated with the treatment, and the potential for control of these metastases. According to White, the trial is still accruing its 143 patients.